baber/WOPTO huggingface dataset:
Patent NZ-514036-A (NZ)
Title: Container with longitudinal passageways
Inventor: ORGYZLO MICHAEL MARIAN
IPC: B65D5/20
Filed: 2001-09-06
Abstract: Described is a ventilated container, comprising: a rectangular bottom panel; and first, second, third and fourth upright panels connected to the bottom panel and extending outwardly therefrom, the first and second upright panels being parallel to each other and perpendicular to the first and second upright panels, the first and second upright panels being connected to the third and fourth upright panels at four corners of the container, the first upright panel having a first longitudinal passageway extending therethrough from the third upright panel to the fourth upright panel to permit air to pass from the third upright panel to the fourth upright panel, the third and fourth upright panels having first apertures respectively aligned with the first passageway, whereby the first passageway communicates through the third and fourth upright panels. Fig. 1 is a perspective view of an apparatus for cooling grapes or other produce including a plurality of containers formed by panels.
Patent NZ-516961-A (NZ)
Title: Medical implant apparatus with wireless energy transmission
Inventor: BLOMBERG AXEL
IPC: A61N1/378
Filed: 2000-08-01
Abstract: A medical implant apparatus include or use an energy transmission means for wireless transmission of energy of a first form from outside a patient's body. An implanted medical device is operable in response to energy of a second form different than the energy of the first form. An implanted energy transforming means transforms energy of the first form wirelessly transmitted by the energy transmission means into energy of the second form for use in the control and operation of the medical device.
Patent NZ-517025-A (NZ)
Title: Antiviral compositions
Inventor: VERRECK GEERT
IPC: A61P31/12
Filed: 2000-08-31
Abstract: Compositions for treatment of viral infection, comprising particles of a compound having either formula (I-A), (I-B), or (I-C).  Also detailed is a process for the preparation of these particles, which includes blending, melt-extrusion and grinding of the components.
Patent NZ-520319-A (NZ)
Title: Diabetic nutritionals
Inventor: GARLEB KEITH A
IPC: A23L33/15
Filed: 2001-02-02
Abstract: The present invention is directed to solid matrix nutritionals designed for the person with diabetes. The two component carbohydrate system of this invention utilizes a source of fructose in combination with at least one nonabsorbent carbohydrate to achieve the same effect of prior art complex multi-component carbohydrate systems. This two component carbohydrate system has the added benefits of tasting good and can be incorporated into solid matrix nutritionals. The solid matrix nutritionals may also include a source of dietary fiber and a source of indigestible oligosaccharides. The solid matrix nutritionals may be administered to a diabetic in the form of cereal, bread, cookies, muffins, bagels, biscuits, crackers and bars. Particularly, the present invention is directed to a nutritional bar designed for the person with diabetes which incorporates the two component carbohydrate system. The present invention is also directed to a method of delivering nutrients to a person with diabetes by feeding the solid matrix nutritionals which incorporates the two component carbohydrate system.
Patent NZ-520907-A (NZ)
Title: Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
Inventor: JENSEN PEDER K
IPC: A61K/
Filed: 1998-12-21
Abstract: A pharmaceutical composition that is useful for the treatment of diseases of the skin, the respiratory tract and concomitant symptoms associated therewith is disclosed, which comprises: (i) an effective amount of at least one leukotriene antagonist selected from montelukast and pranlukast; or a pharmaceutically acceptable salt thereof; in admixture with (ii) an effective amount of at least one antihistamine which is descarboethoxyloratadine, fexofenadine, ebsatine, norastemizole or a pharmaceutically acceptable salt thereof.
Patent NZ-522735-A (NZ)
Title: Biosensor and deposit sensor for monitoring biofilm and other deposits
Inventor: BOETTCHER HELMUT
IPC: G01N17/00
Filed: 2001-06-14
Abstract: A method and apparatus for determining the effectiveness of water treatments in situ (especially in pulp and paper processes) by measuring the amount of deposition of organic and inorganic contaminants, (e.g. biofilm) on a stainless steel coupon suspended in the water. The coupon is attached to a weight sensor within a reservoir tank that includes a fluid inlet and outlet to let water flow over the surface of the coupon to allow contaminants present in the fluid sample to deposit on the coupon surface. At regular intervals, the reservoir tank is drained and the coupon is allowed to dry and is weighed. A computer system attached to the weight sensor can analyse a series of weights and an automated method of adding biocidal agents to the water can be activated if the contaminant level is too high.
Patent NZ-525409-A (NZ)
Title: Software design system and method
Inventor: GRUNDY JOHN
IPC: G06F9/44
Filed: 2003-04-17
Abstract: A method of generating a high level design of a distributed system test bed comprises defining a meta-model of the test bed; defining at least two architecture modeling elements within the meta-model to form an architecture model associated with the meta-model; defining at least one relationship between a pair of architecture modeling elements; defining properties associated with at least one of the architecture modeling elements; and storing the high level design in computer memory. The above method is used to generate a performance test bed by first defining a high level design of the test bed as described above, then generating an XML-encoded architecture design from the high level design and then applying a set of XSLT transformation scripts to the XML-encoded architecture design to generate test bed code. The meta-model of a distributed system test bed is defined by defining at least two modeling elements within the meta-model; defining at least one relationship between a pair of the modeling elements and storing the meta-model in computer memory. The above method of generating a performance test bed is used to evaluate the performance test bed by first generating the performance test bed as described above; then deploying the test bed code; signaling test commands; collecting test results; and analyzing the test results to evaluate the performance test bed.
Patent NZ-527235-A (NZ)
Title: Electrolytic cell regulation method
Inventor: BONNARDEL OLIVIER
IPC: C25C/
Filed: 2002-02-27
Abstract: Disclosed herein is a method for regulating an electrolysis cell for the production of aluminium by reduction of aluminium dissolved in a melted cryolite bath and includes the addition, in the electrolyte bath, during predetermined time intervals p known as periods , of a determined quantity Q(p) of aluminium trifluoride (AlF3) determined by the following ratio: Q(p)=Qint(p)-Qcl(p)+Qt(p), where Qint(p) is an integral (or auto-adaptive ) term representing the total real requirements of the cell in terms of AlF3 which is calculated from an average Qm(p) of the real intake of AlF3 during the last N periods, Qcl is a corrective term corresponding to the equivalent quantity of AlF3 contained in aluminium added to the cell during the period p, and Qt(p) is a corrective term which is a typically increasing function of the difference between the measured temperature of the bath T(p) and a predetermined set temperature. This method enables efficient regulation of the acidity of an electrolysis cell to intensities of up to 500 kA for an electrolyte bath having an AlF3 content which is greater than 11 %.
Patent NZ-528142-A (NZ)
Title: Benzimidazol derivatives modulate chemokine receptors
Inventor: ERIKSSON TOMAS
IPC: C07D413/04
Filed: 2002-03-18
Abstract: Disclosed are compounds of formula (I), wherein: A is O or NH, each X is independently N or CH, Z1 is a bond or (CH2)q, Z2 is a bond or CH2, provided that Z1 and Z2 are do not both simultaneously represent a bond, Q is O, S, CH2 or NH, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases in which modulation of chemokine receptor activity is beneficial.
Patent NZ-534132-A (NZ)
Title: Buffalo milk gangliosides (GS) that are functional equivalents of human GS for use in food products
Inventor: BERGER ALVIN
IPC: A23L33/00
Filed: 2002-12-20
Abstract: Described are gangliosides (GS) derived or isolated from buffalo milk, skimmed buffalo milk, buffalo milk serum or derivatives of either. Buffalo milk is reported to comprise gangliosides that are not contained in bovine milk, such as gangliosides that belong to the GM1-class. Furthermore, buffalo milk is found to comprise unknown gangliosides, denoted herein as ganglioside "F" and "L". Furthermore, the gangliosides are surprisingly found in fractions of isolation procedures that were so far not considered to comprise gangliosides. Finally, milk or milk serum from buffalo, for example as derived from mozzarella cheese production, contains specific gangliosides in the same amounts as human breast milk, which makes it suitable for humanisation of infant and other formulas.
Patent NZ-535009-A (NZ)
Title: DNA encoding a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence and programmed cell death in plants
Inventor: THOMPSON JOHN E
IPC: C12N7/00
Filed: 2000-07-06
Abstract: A composition of a vector for transformation of a plant cell comprises an antisense polynucleotide, either RNA or DNA, which is substantially complementary to a coding strand of a DNA molecule encoding a senescence induced eIF-5A specific sequence. This composition regulates the expression of programmed cell death in plants including age-related or environmental stress-induced senescence. Transgenic plants which display superior qualities such as extended life of flowers, reduced fruit or vegetable spoilage, enhanced biomass, increased seed yield, reduced seed aging and/or reduced yellowing of leaves are produced as a result. Desirable environmental qualities produced include decreased susceptibility to low temperature, drought, infection and/or increased resistance to pathogens.
Patent NZ-536648-A (NZ)
Title: A method of transporting unit loads
Inventor: DICKNER ALLAN
IPC: B61D45/00
Filed: 2003-05-27
Abstract: Unit loads (1) can be transported on an area having a certain length and width, the area for example being the bottom of a standardized container or a loading compartment of a railway goods wagon. In order to improve the filling rate and to obviate damages to the transported goods, the respective lengths and widths of the unit loads to be transported are adjusted to together correspond to the length and width of the area. Further, each unit load is placed on two or more loading ledges (5), each ledge comprising an L-shaped profile having projections (7) for supporting the unit load at a certain distance over its support and being positioned at a lower edge of the unit load.
Patent NZ-540578-A (NZ)
Title: Tetrahydroquinoline derivatives and their use as FSH (follicle stimulating hormone) receptor modulators for fertility regulation
Inventor: KARSTENS WILLEM FREDERIK JOHAN
IPC: C07D409/12
Filed: 2003-12-16
Abstract: Disclosed herein are tetrahydroquinoline derivatives of formula (I) and a pharmaceutically acceptable salt thereof that are FSH (follicle stimulating hormone) receptor modulators, wherein R1 and R2 are H or Me; R3 is H, hydroxy, (1-4C)alkoxy, (di)(1-4C)alkylamino(2-4C)alkoxy or (2-6)heterocycloakl(2-4C)alkoxy; R4 is H, OH, (1-4C)alkoxy or R7; R5 is H, OH, (1-4C)alkoxy or R7, with the proviso that if R4 is H, R5 is not H, OH or (1-4C)alkoxy and that if R5 is H, R4 is not H, OH or (1-4C)alkoxy; R6 is (2-5C)heteroaryl, (6C)aryl, (3-8C)cycloalkyl, (2-6C)heterocycloalkyl or (1-6C)alkyl; R7 is amino, (di)(1-4C) alkylamino, (6C)arylcarbonylamino, (6C)arylcarbonyloxy, (2-5C) heteroarylcarbonylamino, (2-5C)heteroarylcarbonyloxy, R8-(2-4C)alkylamino, R8-(2-4C)alkoxy, R9-methylamino or R9-methoxy; R8 is hydroxy, amino, (1-4C)alkoxy, (di)(1-4C)alkylamino, (2-6C)heterocycloalkyl, (2-6C) heterocycloalkylcarbonylamino, (di)(1-4C)alkylaminocarbonylamino, (1-4C) alkoxycarbonylamino and R9 is aminocarbonyl, (di)(1-4C)alkylaminocarbonyl, (2-5C)heteroaryl or (6C)aryl. Pharmaceutical compositions comprising said tetrahydroquinoline derivatives and the use of these derivatives to regulate fertility are also disclosed.
Patent NZ-543288-A (NZ)
Title: Thermogelling polymer blends for biomaterial applications
Inventor: LOWMAN ANTHONY M
IPC: A61F2/04
Filed: 2004-04-30
Abstract: Disclosed is a thermogelling hydrogel comprising a polymer blend comprising poly(N-isopropyl acrylamide) and a second polymer selected from the group consisting of poly(ethylene glycol), poly(vinyl pyrrolidone) and poly(vinyl alcohol); wherein said polymer blend solidifies from a liquid at room temperature to form a solid hydrogel implant at physiological body temperature.
Patent NZ-545817-A (NZ)
Title: Water jet propulsion thrust vectoring nozzle
Inventor: SCOTT KONRAD
Filed: 2006-03-10
Abstract: A thrust vectoring system for optimising performance and controllability of a water jet propulsion unit is disclosed. A ring (6) is attached about a vertically pivoted axis (1) to the outside of the propulsion unit (7), and a nozzle (4) set partially inside the propulsion unit is attached to the ring by a yolk (3) through a horizontally pivoted axis (2). An actuator (9) operates the ring and the nozzle via the yolk.
Patent NZ-552908-A (NZ)
Title: Indicator agent for noninflammatory stress response and use thereof
Inventor: SEKIYAMA ATSUO
IPC: G01N33/53
Filed: 2005-06-29
Abstract: Disclosed is a use of IL-18 and P38MAP kinase for producing an indicator agent for superoxide-mediated non-inflammatory stress responses. The indicator agent can be used for preventing, ameliorating or predicting a change in immune status based on a non-inflammatory stress response.
Patent NZ-554362-A (NZ)
Title: Apparatus for simultaneous illumination of teeth
Inventor: CIPOLLA ANTHONY J
IPC: A61C5/00
Filed: 2000-10-06
Abstract: An apparatus for the simultaneous illumination of teeth is disclosed. The apparatus comprises a light base having a concave curved surface 15 forming an archway interior space. A plurality of light-generating devices 16 is positioned on the light base to shine light into the archway space. Each of the light-generating devices is arranged to output light in a lobe that overlaps light lobes of other devices. This forms a combined light field of light from plurality of light generating devices of substantially uniform intensity of about 10 to 300 milliwatt per centimetre squared in the archway space, at a distance of up to about two inches from the concave surface.
Patent NZ-561957-A (NZ)
Title: Pallet system
Inventor: TOSSE WARREN HOWARD
Filed: 2007-09-26
Abstract: A pallet system (10), mountable and demountable without the use of tools, for use in the transportation and/or storage of elongate or extruded products is disclosed. The pallet system (10) includes a plurality of base members (13), each base member (11) including inter-lockable elements on at least one end which are adapted to engage and interlock with a similarly configured adjacent base member (11). An elongate base structure can be formed from the base members (11) wherein each of the base members (11) is also adapted to support a plurality of upright members (15), side panels (17) or base extensions (19).
Patent NZ-567340-A (NZ)
Title: Delta-endotoxin genes of bacillus thuringiensis and methods for their use as pesticide
Inventor: CAROZZI NADINE
IPC: C07K14/325
Filed: 2004-02-20
Abstract: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are provided.
Patent NZ-569118-A (NZ)
Title: Agent comprising 5-D-fructose dehydrogenase in combination with one or more other enzymes for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in case of adiposity (obesity)
Inventor: WYROBNIK DANIEL HENRY
IPC: A23L33/20
Filed: 2006-11-23
Abstract: Disclosed is a pharmaceutical composition, a foodstuff, a special foodstuff, a composition of matter or amammalian-ingestable composition of matter comprising 5-D-fructose dehydrogenase in combination with one or more enzyme(s) selected from glucose isomerase, invertase, lactase, maltase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isoamylase, amyloglucosidase and cyclomaltodextrin glucanotransferase.
Patent NZ-569420-A (NZ)
Title: Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
Inventor: ROSINI SERGIO
IPC: A61K31/663
Filed: 2006-12-21
Abstract: Disclosed is a pharmaceutical composition comprising clodronic acid or a salt thereof and hyaluronic acid or a salt thereof and a suitable vehicle useful in the treatment of osteoarthritis.
Patent NZ-569819-A (NZ)
Title: A wind turbine comprising at least one gearbox and an epicyclic gearbox
Inventor: DEMTRODER JENS
IPC: F16H37/04
Filed: 2007-01-25
Abstract: An epicyclic gearbox 11, particularly for the main hub of a wind turbine rotor, includes the gear parts rotating within the confines of a gearbox housing 20, and one or more sensors 16, 21, 24 for measuring vibrations or acoustic emissions of the gearbox, the sensors being mounted on the rotating parts, and in particular on the planet gear shafts 17 or planet carriers 15.
Patent NZ-573951-A (NZ)
Title: 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
Inventor: BOHLMANN ROLF
IPC: A61K31/58
Filed: 2007-06-29
Abstract: Disclosed are 18-methyl-15beta,16beta-methylene-19-nor-20-spiox-4-en-3-one compounds represented by general formula (I). Also disclosed are pharmaceutical compositions comprising the above mentioned compounds of formula (I) and a pharmaceutically acceptable carrier.
Patent NZ-583333-A (NZ)
Title: Medicinal Compositions Containing Honey
Inventor: MOLONEY ANTHONY PETER
IPC: A61K35/644
Filed: 2007-05-31
Abstract: Disclosed is the use of a composition comprising honey from the Leptospermum species wherein the composition is diluted to a water content of at least 19% to 80% water by weight and a water activity of at least 0.63, in the manufacture of a medicament for treating ophthalmic or ear conditions caused by microbial infections and wherein the honey does not include particles with a diameter of greater than 25 microns. (62) Divided Out of 573013
Patent NZ-583642-A (NZ)
Title: Bis-aromatic compounds useful in the treatment of inflammation
Inventor: KATKEVICS MARTINS
IPC: C07C233/75
Filed: 2008-09-03
Abstract: The disclosure relates to bis-aromatic compounds of formula (I): wherein the substituents Y, ring A, D1, D2, D3, L1, Y1, L2, Y2, L3 and Y3 have meanings given in the specification, and pharmaceutically acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
Patent NZ-589944-A (NZ)
Title: Neighbor list messages including femto cell information
Inventor: DESHPANDE MANOJ M
IPC: H04W36/04
Filed: 2009-04-13
Abstract: 589944 Disclosed is a method for neighbour list frequency switching in a terminal (230) in a wireless communication system (200). At least one neighbour list message is received which includes separately demarcated femto cell information and macro cell information. The femto cell information includes femto cell frequencies and the macro cell information includes macro cell frequencies. A switching frequency is from among the macro cell frequencies and femto cell frequencies determined and the terminal (230) is switched to this frequency.
Patent NZ-590236-A (NZ)
Title: Annular submersible vehicle with a sweptback hull shape to minimize vehicle drag
Inventor: GOSLING HARRY GEORGE DENNIS
IPC: B63G8/08
Filed: 2006-10-19
Abstract: Disclosed is a submersible vehicle having an outer hull which defines a hull axis and appears substantially annular when viewed along the hull axis. The interior of the annulus defines a duct which is open at both ends so that when the vehicle is submerged in a liquid, the liquid floods the duct. At least part of the outer hull is swept with respect to the hull axis. A buoyancy control system may be provided. Various methods of deploying and using the vehicle are described.
Patent NZ-595953-A (NZ)
Title: Method and device for treatment of human excrement by separating liquid waste and dehydrating the solid waste
Inventor: LAM DEREK
IPC: A47K11/00
Filed: 2010-03-23
Abstract: 595953 Disclosed is a method and device for treatment of human excrement by dehydrating. The method comprises the following steps: providing a chamber (5) having a top opening through which excrement enters the chamber (5) and allowing solid excrement to form a layer on a porous plate (6) inside the chamber (5) by gravity. Excrement is stored firstly at a front storing region (13) and secondly at a rear storing region (14), and urine is allowed to fall down into a urine storing region (15) through perforations in the porous plate (6). The interior of the chamber (5) is ventilated by a ventilation system. An indirect heat source (7) inside the chamber (5) dries the excrement.
Patent NZ-596800-A (NZ)
Title: Multi-stimulus personal defense device
Inventor: STETHEM KENNETH J
IPC: F41B15/02
Filed: 2010-04-30
Abstract: Disclosed is a baton including an elongate housing (14) with a proximal end (24) and a distal end (26). The housing (14) defines a first compartment (156) located proximate the proximal end (24) and a second compartment (158) located proximate the distal end (26). Also included is a power source (157) located in the first compartment (156). The second compartment (158) is adapted to removably receive interchangeably from the distal end (26) an operative component (30) selected from the group consisting of a training module, a light source, a laser generator, a sound generator, an incapacitation waveform generator, and combinations thereof. The operative component (30) comprises a connection element to secure the operative component (30) within the second compartment. The connection element is secured with a fastener which is accessed from the first compartment (156).
Patent NZ-596979-A (NZ)
Title: Anti-allergic agent comprising a fermentation product of a propionic acid bacterium
Inventor: KANO HIROSHI
IPC: A61K35/20
Filed: 2009-02-26
Abstract: Disclosed is the use of a fermentation product of a propionic acid bacterium in the preparation of a medicament for the prevention and/or improvement of dry skin conditions, wherein the propionic acid bacterium is selected from the group comprising Propionibacterium freudenreichii, Propionibacterium thoenii, and Propionibacterium acidpropionici.